AMENDMENT TO LICENSE AGREEMENT (UM97-14)License Agreement • May 6th, 2013 • Heat Biologics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 6th, 2013 Company IndustryAmendment to the License Agreement (the "Amendment") dated the 11th day of July, 2008 (the "Effective Date"), by and between the University of Miami and its School of Medicine ("LICENSOR"), and HEAT BIOLOGICS, INC., a Delaware corporation ("LICENSEE"), under the direction of Dr. Eckhard Podack, to wit: LICENSE AGREEMENT relating to the technology and product identified as the Podack Cancer Vaccine (VM97-14) , and hereinafter referred to as "License Agreement".
AMENDMENT TO LICENSE AGREEMENT (UM97-14)License Agreement • February 12th, 2013 • Heat Biologics, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 12th, 2013 Company IndustryAmendment to the License Agreement (the "Amendment") dated the 11th day of July, 2008 (the "Effective Date"), by and between the University of Miami and its School of Medicine ("LICENSOR"), and HEAT BIOLOGICS, INC., a Delaware corporation ("LICENSEE"), under the direction of Dr. Eckhard Podack, to wit: LICENSE AGREEMENT relating to the technology and product identified as the Podack Cancer Vaccine (VM97-14) , and hereinafter referred to as "License Agreement".